Somerville, MA, United States of America

Michael Tworoger

This inventor holds 2 USPTO granted patents. Top assignee: Genetic Services, Inc.. Active years: 2010-2012.


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2010-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael Tworoger: Innovator in Embryo Transformation Technologies

Introduction

Michael Tworoger is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of genetic services, particularly in the area of embryo transformation technologies. With a total of 2 patents, his work has advanced the methods and systems used in genetic research.

Latest Patents

Tworoger's latest patents focus on systems that enable reliable multiplexed transformation of embryos. These inventions provide methods and reagents for preparing injection-quality nucleic acid samples, allowing for the simultaneous preparation of multiple samples. Additionally, his patents include systems for the simultaneous processing of multiple injected embryos. The methods he developed involve the use of virginator strains, which enhance the efficiency of setting up crosses necessary for producing eggs for injections and screening for transformants.

Career Highlights

Michael Tworoger is associated with Genetic Services, Inc., where he applies his expertise in genetic technologies. His innovative approaches have positioned him as a key figure in the field, contributing to advancements that benefit research institutions and genetic studies.

Collaborations

Tworoger collaborates with various professionals in his field, including his coworker, Susan B Zusman. Their combined efforts contribute to the ongoing development of cutting-edge genetic technologies.

Conclusion

Michael Tworoger's work in embryo transformation technologies exemplifies the impact of innovation in genetic research. His patents and collaborations continue to push the boundaries of what is possible in the field, making significant strides in the understanding and manipulation of genetic materials.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…